• OPEN AN ACCOUNT
Indian Indices
Sensex
83,576.24 -604.72
( -0.72%)
Global Indices
Nasdaq
49,520.87 233.75
(0.47%)
Dow Jones
6,986.78 44.32
(0.64%)
Hang Seng
51,918.01 800.75
(1.57%)
Nikkei 225
10,123.15 78.46
(0.78%)
Forex
USD-INR
89.91 -0.02
(-0.02%)
EUR-INR
104.90 -0.20
(-0.19%)
GBP-INR
120.86 -0.43
(-0.35%)
JPY-INR
0.57 0.00
(-0.15%)

EQUITY - MARKET SCREENER

Union Bank of India
Industry :  Banks - Public Sector
BSE Code
ISIN Demat
Book Value()
532477
INE692A01016
151.6107853
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
UNIONBANK
6.9
123817.08
EPS(TTM)
Face Value()
Div & Yield %
23.52
10
2.93
 

Marksans Pharma receives USFDA approval for Loperamide Hydrochloride tablets
Nov 19,2025

Marksans Pharma announced USFDA final approval of the Company's wholly owned subsidiary Marksans Pharma Inc.'s Abbreviated New Drug Application (ANDA) for Loperamide Hydrochloride Tablets USP, 2 mg (OTC). This product is bioequivalent to the reference listed drug (RLD), Imodium A-D Tablets, 2mg, of Kenvue Brands LLC (Kenvue) NDA - 019860.

 Loperamide Hydrochloride is an anti-diarrheal medication used to control symptoms of acute and chronic diarrhea.